Methotrexate Market - Top Companies and Manufacturers

  • Report ID: 6872
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Methotrexate Landscape

    Key players in the methotrexate market are employing several organic and inorganic tactics such as new product launches, technological innovations, investments in R&D, strategic collaborations & partnerships, mergers & acquisitions, and global expansions to earn high profits and maximize their presence. Industry giants are collaborating with research organizations and partnering with other players to develop innovative methotrexate drug formulations. They are also acquiring smaller pharma companies or start-ups with advanced methotrexate formulations to expand their product offering at minimum CAPEX. Furthermore, the regional expansion tactics are aiding them to grab untapped opportunities.

    Some of the key players include in methotrexate market:

    • Pharmascience, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Eversana Life Science Services, LLC
    • Elite Pharmaceuticals, Inc.
    • STAQ Pharma
    • PrecisePK
    • Novartis AG
    • Pfenex, Inc.
    • Zydus Lifesciences
    • Alvogen
    • Teva Pharmaceutical Industries
    • Bristol-Myers Squibb
    • Mylan N.V.
    • Hikma Pharmaceuticals Plc
    • Fresenius Kabi
    • Reddy's Laboratories
    • Aurobindo Pharma Ltd
    • Accord Healthcare Limited
    • Amgen, Inc.
    • Sun Pharmaceutical Industries
    • Sandoz Group AG

Browse Key Market Insights with Data Illustration:

In the News

  • In March 2024, Pharmascience, Inc. announced the launch of its new methotrexate injection of 50 mg/ml in Canada. This product line is estimated to be effective for the treatment of psoriasis, psoriatic arthritis, and rheumatoid arthritis in adults.
  • In December 2023, Shorla Oncology & Eversana Life Science Services, LLC announced the launch of FDA-approved JYLAMVO the first methotrexate solution in the U.S. This solution is effective for the treatment of adults with acute lymphoblastic leukemia as part of a combination chemotherapy.

Author Credits:  Radhika Pawar


  • Report ID: 6872
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The global methotrexate market will be valued at USD 9.9 billion in 2025.

Expanding at a CAGR of 3.6%, the global market is expected to increase from USD 9.6 billion in 2024 to USD 15.1 billion by 2037.

Some leading companies are Pfenex, Inc., Zydus Lifesciences, Alvogen, Teva Pharmaceutical Industries, Bristol-Myers Squibb, and Mylan N.V.

The cancer treatment segment is estimated to capture a high 54.3% of the market share through 2037.

North America is expected to hold 33.7% of the global market share through 2037.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample